期刊
CELL
卷 184, 期 3, 页码 655-+出版社
CELL PRESS
DOI: 10.1016/j.cell.2020.12.024
关键词
-
资金
- Hercules [AKUL/11/37]
- FWO [G.0929.15]
- German Tuberous Sclerosis Foundation
- German Research Foundation [TH 1358/3-1, SFB 430 1389, EXC 294, EXC-2189, 390939984, CRC850, CRC1381]
- Graduate School of Medical Sciences of the University of Groningen
- German TS Foundation
- Stichting TSC Fonds
- TS Alliance UK
- TS Association UK
- BMBF e:Med initiative MAPTor-NET [031A426B]
- BMBF e:Med initiative GlioPATH [01ZX1402]
- Rosalind Franklin Fellowship of the University of Groningen
- PoLiMeR Innovative Training Network (Marie Sklodowska-Curie grant) [812616]
- MESI-STRAT project from the European Union Horizon 2020 Research and Innovation Program [754688]
- European Research Council (ERC) under the European Union Horizon 2020 Research and Innovation Program [757729]
- Max Planck Society
- Austrian Science Fund [FWF DK W11, P32608]
- Molecular Cell Biology and Oncology PhD Program at the Medical University of Innsbruck (MCBO)
- Fund for O6260 Research Foundation-Flanders (FWO [11F2919N]
- British Skin Foundation
- University of Bristol
- long-term EMBO postdoctoral fellowship [ALT-755-2018]
- TEAM grant from the Foundation for Polish Science [POIR.04.04.00-00-5CBE/17-00]
- Polish National Science Centre Etiuda grant [2020/36/T/NZ3/00132]
- University of Leuven [C32/18/067]
- Fellowship for Extraordinary Young Scientists from the Polish Ministry of Science and Higher Education
- Ser Cymru II Precision Medicine Fellowship
- National Institute for Health Research
- NHS England
- Wellcome Trust
- Cancer Research UK
- Medical Research Council
- National Health Service
- MRC [MC_PC_16035] Funding Source: UKRI
- European Research Council (ERC) [757729] Funding Source: European Research Council (ERC)
- Austrian Science Fund (FWF) [P32608] Funding Source: Austrian Science Fund (FWF)
- Marie Curie Actions (MSCA) [812616] Funding Source: Marie Curie Actions (MSCA)
- H2020 Societal Challenges Programme [754688] Funding Source: H2020 Societal Challenges Programme
The study found that Ras GTPase-activating protein-binding proteins 1 and 2 are core components of stress granules and play a key role at the cytoplasmic surface of lysosomes. They anchor the tuberous sclerosis complex protein complex to lysosomes in a non-redundant manner, suppressing the activation of mTORC1. Deficiency in G3BP1 can lead to phenotypes related to mTORC1 hyperactivity, and low G3BP1 levels in tumors enhance mTORC1-driven cell motility and correlate with poor outcomes in patients. Additionally, inhibition of G3bp1 in zebrafish affects neuronal development and function.
Ras GTPase-activating protein-binding proteins 1 and 2 (G3BP1 and G3BP2, respectively) are widely recognized as core components of stress granules (SGs). We report that G3BPs reside at the cytoplasmic surface of lysosomes. They act in a non-redundant manner to anchor the tuberous sclerosis complex (TSC) protein complex to lysosomes and suppress activation of the metabolic master regulator mechanistic target of rapamycin complex 1 (mTORC1) by amino acids and insulin. Like the TSC complex, G3BP1 deficiency elicits phenotypes related to mTORC1 hyperactivity. In the context of tumors, low G3BP1 levels enhance mTORC1-driven breast cancer cell motility and correlate with adverse outcomes in patients. Furthermore, G3bp1 inhibition in zebrafish disturbs neuronal development and function, leading to white matter heterotopia and neuronal hyperactivity. Thus, G3BPs are not only core components of SGs but also a key element of lysosomal TSC-mTORC1 signaling.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据